S2 Ep3 Bridging the AI Enthusiasm Gap

AI makes scaling easy - the winners use it to do better, not just more, by keeping human judgment in the loop.Shownotes:Most life science teams are stuck talking about AI transformation while competitors execute it. The gap between 68% AI optimism and 7% power users isn't about awareness - it's about execution.This episode is for biotech marketers and product managers navigating AI adoption and product development decisions. Matt and Jasmine explore why organisations retire risk by standardising rather than solving creatively - a pattern that undermines both AI implementation and product differentiation. The key insight: AI makes it dangerously easy to produce more without asking if the strategy underneath is broken. The winners use AI to do better, not just more.What you will learn:Why "secret cyborgs" using free AI tools with zero guardrails are a symptom of execution failureHow to move personas from static PDFs to interactive synthetic customers you can queryWhen to pause AI implementation because you're optimising the wrong workWhy Stage Gate committees systematically prune differentiation before launchHow product managers can defend customer pain points with veto authorityThe connection between AI pilot mode and launching commoditised productsKeywords: AI implementation life science, synthetic customer persona, AI execution gap, Stage Gate product development, biotech marketing strategy, AI guardrails, product differentiation, crossing the chasm life science, voice of customer, AI literacyWatch the full episode, subscribe for weekly insights, and visit strivenn.com for tools to close your own execution gaps.